These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20373033)

  • 1. Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase.
    Shen LL; Liu H; Peng J; Gan L; Lu L; Zhang Q; Li L; He F; Jiang Y
    Mol Biol Rep; 2011 Jan; 38(1):553-9. PubMed ID: 20373033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesoid X receptor represses hepatic lipase gene expression.
    Sirvent A; Verhoeven AJ; Jansen H; Kosykh V; Darteil RJ; Hum DW; Fruchart JC; Staels B
    J Lipid Res; 2004 Nov; 45(11):2110-5. PubMed ID: 15342685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.
    Matsukuma KE; Bennett MK; Huang J; Wang L; Gil G; Osborne TF
    J Lipid Res; 2006 Dec; 47(12):2754-61. PubMed ID: 16957179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
    Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.
    Bilz S; Samuel V; Morino K; Savage D; Choi CS; Shulman GI
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E716-22. PubMed ID: 16291572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice.
    Li L; Liu H; Peng J; Wang Y; Zhang Y; Dong J; Liu X; Guo D; Jiang Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):880-5. PubMed ID: 24211198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.
    Singh AB; Dong B; Kraemer FB; Xu Y; Zhang Y; Liu J
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2448-2459. PubMed ID: 30354208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of farnesoid X receptor promotes triglycerides lowering by suppressing phospholipase A2 G12B expression.
    Liu Q; Yang M; Fu X; Liu R; Sun C; Pan H; Wong CW; Guan M
    Mol Cell Endocrinol; 2016 Nov; 436():93-101. PubMed ID: 27471003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter.
    Renga B; Migliorati M; Mencarelli A; Cipriani S; D'Amore C; Distrutti E; Fiorucci S
    Biochim Biophys Acta; 2011 Mar; 1809(3):157-65. PubMed ID: 21296199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
    Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B
    FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells.
    Xu Z; Huang G; Gong W; Zhao Y; Zhou P; Zeng Y; He F
    J Interferon Cytokine Res; 2012 Nov; 32(11):517-23. PubMed ID: 22817871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
    Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
    Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition.
    Renga B; Mencarelli A; D'Amore C; Cipriani S; Baldelli F; Zampella A; Distrutti E; Fiorucci S
    FASEB J; 2012 Jul; 26(7):3021-31. PubMed ID: 22447981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR.
    Dong B; Singh AB; Guo GL; Young M; Liu J
    Int J Mol Med; 2019 May; 43(5):1927-1938. PubMed ID: 30896855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FXR controls CHOP expression in steatohepatitis.
    Fuchs CD; Claudel T; Scharnagl H; Stojakovic T; Trauner M
    FEBS Lett; 2017 Oct; 591(20):3360-3368. PubMed ID: 28895119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
    Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
    Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats.
    Cipriani S; Mencarelli A; Palladino G; Fiorucci S
    J Lipid Res; 2010 Apr; 51(4):771-84. PubMed ID: 19783811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.